256 findings · Molecular · published 2017+
- MolecularStrong
CE/BZA increased serum high-density lipoprotein (HDL)-cholesterol and serum markers of hepatic de novo lipogenesis.
CE/BZA may improve HDL cholesterol levels and influence fat metabolism.
Supports 2020 - MolecularStrong
Yoga significantly improved the expression of OGG1 protein, indicating enhanced DNA repair in T2D subjects (17.55; P = .034).
Yoga may enhance DNA repair mechanisms in individuals with type 2 diabetes.
Supports 2021 - MolecularStrong
The beneficial effect of yoga on DNA damage in T2D subjects is mediated by the mitigation of oxidative DNA damage and enhancement of DNA repair.
Yoga's benefits for DNA damage in type 2 diabetes are linked to its effects on oxidative stress and DNA repair.
Supports 2021 - MolecularStrong
The amino acid profile of bread with 5% WSF is higher than that of the control bread.
Using WSF can enhance the amino acid content of bread, beneficial for nutrition.
Supports 2023 - MolecularStrong
Conventional antihyperglycemic medications have minimal effect on lowering cardiovascular risk in T2DM patients.
Practitioners should be aware that conventional medications may not effectively reduce cardiovascular risk in T2DM patients.
Supports 2018 - MolecularStrong
Higher concentration of nicotinamide phosphoribosyltransferase (NAMPT) protein is associated with faster phosphocreatine (PCr) resynthesis.
Increasing NAMPT levels may enhance muscle recovery rates post-exercise.
Supports 2020 - MolecularStrong
31P-MRS based PCr resynthesis may represent a valid non-invasive surrogate marker of mitochondrial NAMPT in human skeletal muscle.
31P-MRS can be used as a non-invasive method to assess mitochondrial health in muscle.
Supports 2020 - MolecularStrong
Compounds K2 and K5 decreased and maintained the body weight of diet-induced obese mice.
Compounds K2 and K5 may be potential candidates for drug development targeting obesity.
Supports 2023 - MolecularStrong
The study proposes an approach for treating overweight and obese patients by preventing or reducing CCK1 activation.
This approach may inform future obesity treatments focusing on CCK1 regulation.
Supports 2023 - MolecularStrong
Adipose tissue browning is linked to improved metabolic and cardiovascular health.
Promoting adipose tissue browning may enhance metabolic and cardiovascular health.
Supports 2025New - MolecularStrong
White adipose tissue browning mitigates inflammation and improves cardiometabolic health.
Encouraging white adipose tissue browning may reduce inflammation and enhance cardiometabolic health.
Supports 2025New - MolecularStrong
A one standard deviation higher polygenic score (PS) related to a smaller one-year change in waist circumference adjusted for body mass index (WCadjBMI) in the lifestyle intervention arms at year 1, predicting poorer response among White participants overall.
Practitioners should consider genetic factors when assessing weight loss responses in individuals.
Supports 2022 - MolecularStrong
The effect of polygenic risk on change in WCadjBMI with lifestyle intervention is small and not of sufficient magnitude to be clinically significant.
Genetic factors may play a role in weight loss, but their impact may not be significant enough to warrant changes in intervention strategies.
Qualifies 2022 - MolecularStrong
Modern pharmacotherapies are fundamental to CKD prevention.
Incorporate modern pharmacotherapies into CKD prevention strategies.
Supports 2026New - MolecularStrong
Circadian cues direct hormones, enzymes, and molecular signals.
Recognizing the impact of circadian cues can aid in timing interventions for better health outcomes.
Supports 2020 - MolecularStrong
The Mediterranean Adequacy Index (MAI) is inversely correlated with the Atherogenicity (ATI) index (R = -0.91).
Practitioners should consider the MAI as a significant dietary factor in cardiovascular health.
Supports 2025New - MolecularStrong
Atherogenicity (ATI) is directly correlated with serum cholesterol (R = +0.73).
Practitioners should monitor serum cholesterol levels in relation to dietary fatty acid intake.
Supports 2025New - MolecularStrong
Atherogenicity (ATI) and Thrombogenicity (THI) indices are strongly associated with long-term coronary heart disease (CHD) mortality.
Practitioners should consider the impact of dietary fatty acids on long-term CHD risk.
Supports 2025New - MolecularStrong
Emerging biomarkers and diagnostic tools could improve early detection of diabetic neuropathy.
Practitioners should consider new biomarkers for better early diagnosis of diabetic neuropathy.
Supports 2018 - MolecularStrong
IgG antibody concentrations decreased in 60% of the foods in the waitlist group.
Even without intervention, some individuals may experience changes in IgG levels.
Qualifies 2018 - MolecularStrong
T2DM-associated sphingolipids were associated with poorer memory, attention, and psychomotor processing speed performance.
Practitioners should consider the impact of T2DM-related sphingolipids on cognitive performance in patients with CAD.
Supports 2019 - MolecularStrong
The FDA-approved label for resmetirom does not require liver biopsy to confirm the diagnosis of fibrotic MASH.
Clinicians can diagnose fibrotic MASH without the need for invasive liver biopsy, simplifying patient assessment.
Supports 2024 - MolecularStrong
Nutritional biology can significantly contribute to the discovery of new molecular targets.
Practitioners should consider the role of nutrition in identifying new treatment targets.
Supports 2018 - MolecularStrong
Several mechanisms may mediate the association between NAFLD and CVD.
Understanding these mechanisms can help in developing targeted interventions for patients with NAFLD.
Supports 2021